rss

Author index

December 1997, Volume 50, Issue 6

[Table of contents][Advertising PDF]
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Abrahamson, M

    • Modification of cystatin C activity by bacterial proteinases and neutrophil elastase in periodontitis. Mol Path 1997;50:291-297 doi:10.1136/mp.50.6.291

  2. Araya, J C

    • Double immunostaining for p53 and molecular chaperone hsp72/73 in gastric carcinoma. Mol Path 1997;50:317-321 doi:10.1136/mp.50.6.317

B

  1. Bellas, C

    • Microvessel density, p53 overexpression, and apoptosis in invasive breast carcinoma. Mol Path 1997;50:304-309 doi:10.1136/mp.50.6.304

  2. Bromidge, T J

    • Heterogeneity of clonal lymphocytes with regard to bcl-2 protein concentration and cell size. Mol Path 1997;50:326-328 doi:10.1136/mp.50.6.326

  3. Bruton, R

    • Cadherin and catenin biology represent a global mechanism for epithelial cancer progression. Mol Path 1997;50:289-290 doi:10.1136/mp.50.6.289

D

  1. Davidoff, M S

    • Immunohistochemical pattern of insulin-like growth factor (IGF) I, IGF II and IGF binding proteins 1 to 6 in carcinoma in situ of the testis. Mol Path 1997;50:298-303 doi:10.1136/mp.50.6.298

  2. Drescher, B

    • Immunohistochemical pattern of insulin-like growth factor (IGF) I, IGF II and IGF binding proteins 1 to 6 in carcinoma in situ of the testis. Mol Path 1997;50:298-303 doi:10.1136/mp.50.6.298

F

  1. Fegan, C

    • Leucocyte Antigen Facts Book Mol Path 1997;50:329-330 doi:10.1136/mp.50.6.329-c

  2. Flores, P

    • Double immunostaining for p53 and molecular chaperone hsp72/73 in gastric carcinoma. Mol Path 1997;50:317-321 doi:10.1136/mp.50.6.317

G

  1. Gonzalez-Palacios, F

    • Microvessel density, p53 overexpression, and apoptosis in invasive breast carcinoma. Mol Path 1997;50:304-309 doi:10.1136/mp.50.6.304

H

  1. Hall, A

    • Modification of cystatin C activity by bacterial proteinases and neutrophil elastase in periodontitis. Mol Path 1997;50:291-297 doi:10.1136/mp.50.6.291

  2. Hartmann, M

    • Immunohistochemical pattern of insulin-like growth factor (IGF) I, IGF II and IGF binding proteins 1 to 6 in carcinoma in situ of the testis. Mol Path 1997;50:298-303 doi:10.1136/mp.50.6.298

  3. Houlston, R S

    • Genetic prognostic markers in colorectal cancer. Mol Path 1997;50:281-288 doi:10.1136/mp.50.6.281

  4. Howe, D J

    • Heterogeneity of clonal lymphocytes with regard to bcl-2 protein concentration and cell size. Mol Path 1997;50:326-328 doi:10.1136/mp.50.6.326

J

  1. Jankowski, J A

    • Cadherin and catenin biology represent a global mechanism for epithelial cancer progression. Mol Path 1997;50:289-290 doi:10.1136/mp.50.6.289

  2. Johnson, S A

    • Heterogeneity of clonal lymphocytes with regard to bcl-2 protein concentration and cell size. Mol Path 1997;50:326-328 doi:10.1136/mp.50.6.326

K

  1. Keith, W N

    • Amplification of fluorescent in situ hybridisation signals in formalin fixed paraffin wax embedded sections of colon tumour using biotinylated tyramide. Mol Path 1997;50:322-325 doi:10.1136/mp.50.6.322

L

  1. Lauke, H

    • Immunohistochemical pattern of insulin-like growth factor (IGF) I, IGF II and IGF binding proteins 1 to 6 in carcinoma in situ of the testis. Mol Path 1997;50:298-303 doi:10.1136/mp.50.6.298

M

  1. Martinerie, C

    • Chromosomal mapping and expression of the human cyr61 gene in tumour cells from the nervous system. Mol Path 1997;50:310-316 doi:10.1136/mp.50.6.310

  2. Martinez, J C

    • Microvessel density, p53 overexpression, and apoptosis in invasive breast carcinoma. Mol Path 1997;50:304-309 doi:10.1136/mp.50.6.304

  3. McKay, J A

    • Amplification of fluorescent in situ hybridisation signals in formalin fixed paraffin wax embedded sections of colon tumour using biotinylated tyramide. Mol Path 1997;50:322-325 doi:10.1136/mp.50.6.322

  4. McLeod, H L

    • Amplification of fluorescent in situ hybridisation signals in formalin fixed paraffin wax embedded sections of colon tumour using biotinylated tyramide. Mol Path 1997;50:322-325 doi:10.1136/mp.50.6.322

  5. Murray, G I

    • Amplification of fluorescent in situ hybridisation signals in formalin fixed paraffin wax embedded sections of colon tumour using biotinylated tyramide. Mol Path 1997;50:322-325 doi:10.1136/mp.50.6.322

N

  1. Nguyen, V C

    • Chromosomal mapping and expression of the human cyr61 gene in tumour cells from the nervous system. Mol Path 1997;50:310-316 doi:10.1136/mp.50.6.310

O

  1. Oates, J

    • Molecular Diagnosis of Cancer Mol Path 1997;50:330 doi:10.1136/mp.50.6.330-b

P

  1. Paydaś, S

    • p53 mutations in multiple myeloma. Mol Path 1997;50:329 doi:10.1136/mp.50.6.329-a

  2. Perbal, B

    • Chromosomal mapping and expression of the human cyr61 gene in tumour cells from the nervous system. Mol Path 1997;50:310-316 doi:10.1136/mp.50.6.310

  3. Potempa, J

    • Modification of cystatin C activity by bacterial proteinases and neutrophil elastase in periodontitis. Mol Path 1997;50:291-297 doi:10.1136/mp.50.6.291

R

  1. Ramsden, D B

    • Molecular Endocrinology: Genetic Analysis of Hormones and their Receptors Mol Path 1997;50:329 doi:10.1136/mp.50.6.329-b

  2. Renvert, S

    • Modification of cystatin C activity by bacterial proteinases and neutrophil elastase in periodontitis. Mol Path 1997;50:291-297 doi:10.1136/mp.50.6.291

  3. Roa, I

    • Double immunostaining for p53 and molecular chaperone hsp72/73 in gastric carcinoma. Mol Path 1997;50:317-321 doi:10.1136/mp.50.6.317

  4. Roa, J C

    • Double immunostaining for p53 and molecular chaperone hsp72/73 in gastric carcinoma. Mol Path 1997;50:317-321 doi:10.1136/mp.50.6.317

  5. Rule, S A

    • Heterogeneity of clonal lymphocytes with regard to bcl-2 protein concentration and cell size. Mol Path 1997;50:326-328 doi:10.1136/mp.50.6.326

S

  1. Sahin, B

    • p53 mutations in multiple myeloma. Mol Path 1997;50:329 doi:10.1136/mp.50.6.329-a

  2. Sancho, M

    • Microvessel density, p53 overexpression, and apoptosis in invasive breast carcinoma. Mol Path 1997;50:304-309 doi:10.1136/mp.50.6.304

  3. Sanders, D S

    • Cadherin and catenin biology represent a global mechanism for epithelial cancer progression. Mol Path 1997;50:289-290 doi:10.1136/mp.50.6.289

  4. Seyrek, E

    • p53 mutations in multiple myeloma. Mol Path 1997;50:329 doi:10.1136/mp.50.6.329-a

  5. Shepherd, N

    • Cadherin and catenin biology represent a global mechanism for epithelial cancer progression. Mol Path 1997;50:289-290 doi:10.1136/mp.50.6.289

T

  1. Tigme, Paddy

    • Immunoglobulin Genes. 2nd edn Mol Path 1997;50:330 doi:10.1136/mp.50.6.330-a

  2. Tomlinson, I P

    • Genetic prognostic markers in colorectal cancer. Mol Path 1997;50:281-288 doi:10.1136/mp.50.6.281

V

  1. Viegas-Pequignot, E

    • Chromosomal mapping and expression of the human cyr61 gene in tumour cells from the nervous system. Mol Path 1997;50:310-316 doi:10.1136/mp.50.6.310

  2. Villaseca, M A

    • Double immunostaining for p53 and molecular chaperone hsp72/73 in gastric carcinoma. Mol Path 1997;50:317-321 doi:10.1136/mp.50.6.317

W

  1. Wikström, M

    • Modification of cystatin C activity by bacterial proteinases and neutrophil elastase in periodontitis. Mol Path 1997;50:291-297 doi:10.1136/mp.50.6.291

Z

  1. Zorludemir, S

    • p53 mutations in multiple myeloma. Mol Path 1997;50:329 doi:10.1136/mp.50.6.329-a

  2. Zumkeller, W

    • Immunohistochemical pattern of insulin-like growth factor (IGF) I, IGF II and IGF binding proteins 1 to 6 in carcinoma in situ of the testis. Mol Path 1997;50:298-303 doi:10.1136/mp.50.6.298

    • Pathology jobs

    Pathology jobs

    Show me all >>